SPOC

INanoBio's mission is to develop high-accuracy early stage disease diagnostics using transformative nano-biotechnology platforms and machine learning. Our goal is to extract systems scale information from complex disease biology, identify and detect disease specific molecular biomarkers, signatures at prodromal or pre-symptomatic stages. We believe most diseases can be detected early, enabling early personalized therapeutic intervention to preempt full development of diseases, ushering in preemptive medicine in two to three decades.

Primary location: Scottsdale United States